Emerging Agents in the Pipeline for Merkel Cell Carcinoma
2 Visualizações
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Mostre mais
Comentários do Facebook
Nenhum comentário encontrado